Loading...

Endonovo Therapeutics, Inc.

ENDVPNK
Healthcare
Biotechnology
$0.00
$0.00(0.00%)

Endonovo Therapeutics, Inc. (ENDV) Company Profile & Overview

Explore Endonovo Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Endonovo Therapeutics, Inc. (ENDV) Company Profile & Overview

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

SectorHealthcare
IndustryBiotechnology
CEOAlan Brian Collier

Contact Information

800 489 4774
6320 Canoga Avenue, Woodland Hills, CA, 91367

Company Facts

1 Employees
IPO DateNov 15, 2012
CountryUS
Actively Trading

Frequently Asked Questions

;